- Investing Ideas
- Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Canadian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
8
Value score of at least 4 focused on companies with a low market cap.
8 companies
Decibel Cannabis
Market Cap: CA$72.1m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.13
7D
0%
1Y
127.3%
Herbal Dispatch
Market Cap: CA$5.6m
Owns and operates cannabis e-commerce platforms in Canada and the United States.
HERB
CA$0.045
7D
0%
1Y
-18.2%
SOL Global Investments
Market Cap: CA$1.1m
A private equity firm specializing in emerging growth.
SOL
CA$0.04
7D
-20.0%
1Y
-95.3%
Medicure
Market Cap: CA$12.7m
A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.
MPH
CA$1.22
7D
8.9%
1Y
56.4%
Avant Brands
Market Cap: CA$10.1m
Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.
AVNT
CA$0.68
7D
0%
1Y
-29.9%
InnoCan Pharma
Market Cap: CA$29.6m
Operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally.
INNO
CA$6.58
7D
-1.2%
1Y
-40.5%
Delivra Health Brands
Market Cap: CA$4.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.13
7D
-13.3%
1Y
-23.5%
Nextleaf Solutions
Market Cap: CA$9.3m
A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.
OILS
CA$0.055
7D
10.0%
1Y
-8.3%